_id
6911c6d4ccc777a4e85d659e
Ticker
HOWL
Name
Werewolf Therapeutics Inc
Exchange
NASDAQ
Address
200 Talcott Ave, Watertown, MA, United States, 02472
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://werewolftx.com
Description
Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. The company designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies through its proprietary PREDATOR platform. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced or metastatic solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of advanced or metastatic solid tumors and lymphoma. The company is also developing JZP898, a conditionally activated interferon alpha INDUKINE molecule for the treatment of cancer; WTX-921, a conditionally activated IL-10 INDUKINE molecule for the treatment of inflammatory bowel disease and potentially other inflammatory diseases; and WTX-712, an activated Interleukin-21(IL-21) and WTX-518, an activated IL-18 (IL-18) INDUKINE molecule for the treatment of cancer. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Watertown, Massachusetts.
Last Close
1.09
Volume
124297
Current Price
1.1
Change
0.9174311926605512
Last Updated
2025-12-01T08:56:14.652Z
Image
data:image/webp;base64,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
Ipo Date
2021-04-30T00:00:00.000Z
Market Cap
48540200
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.995
Sentiment Sources
1
Rating
4.6667
Target Price
6.1667
Strong Buy
4
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
15726000
Operating Income
-15726000
Interest Expense
644000
Pretax Income
-16370000
Net Income
-16370000
Eps
-0.3573920397680187
Dividends Per Share
-
Shares Outstanding
48540200
Income Tax Expense
-
EBITDA
-15324000
Operating Margin
-
Total Other Income Expense Net
-644000
Cash
65711000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
68173000
Property Plant Equipment
10510000
Total Assets
79627000
Payables
1078000
Short Term Debt
7504000
Long Term Debt
21656000
Total Liabilities
50013000
Equity
29614000
Depreciation
402000
Change In Working Capital
60000
Cash From Operations
-15156000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
3274000
Net Change In Cash
-11882001
PE
-
PB
1.7013725332612957
ROE
-55.27790909704869
ROA
-20.55835332236553
FCF
-15156000
Fcf Percent
-
Piotroski FScore
1
Health Score
33
Deep Value Investing Score
3
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
2.8
Garp Investing Score
1
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
1.5
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
15726000
Quarters > 0 > income Statement > operating Income
-15726000
Quarters > 0 > income Statement > interest Expense
644000
Quarters > 0 > income Statement > pretax Income
-16370000
Quarters > 0 > income Statement > net Income
-16370000
Quarters > 0 > income Statement > eps
-0.3573920397680187
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
45804042
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-15324000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-644000
Quarters > 0 > balance Sheet > cash
65711000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
68173000
Quarters > 0 > balance Sheet > property Plant Equipment
10510000
Quarters > 0 > balance Sheet > total Assets
79627000
Quarters > 0 > balance Sheet > payables
1078000
Quarters > 0 > balance Sheet > short Term Debt
7504000
Quarters > 0 > balance Sheet > long Term Debt
21656000
Quarters > 0 > balance Sheet > total Liabilities
50013000
Quarters > 0 > balance Sheet > equity
29614000
Quarters > 0 > cash Flow > net Income
-16370000
Quarters > 0 > cash Flow > depreciation
402000
Quarters > 0 > cash Flow > change In Working Capital
60000
Quarters > 0 > cash Flow > cash From Operations
-15156000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
3274000
Quarters > 0 > cash Flow > net Change In Cash
-11882001
Quarters > 0 > ratios > PE
-0.3573920397680187
Quarters > 0 > ratios > PB
1.7013725332612957
Quarters > 0 > ratios > ROE
-55.27790909704869
Quarters > 0 > ratios > ROA
-20.55835332236553
Quarters > 0 > ratios > FCF
-15156000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
33
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
406000
Quarters > 1 > income Statement > gross Profit
-406000
Quarters > 1 > income Statement > operating Expenses
17136000
Quarters > 1 > income Statement > operating Income
-17542000
Quarters > 1 > income Statement > interest Expense
1301000
Quarters > 1 > income Statement > pretax Income
-17982000
Quarters > 1 > income Statement > net Income
-17982000
Quarters > 1 > income Statement > eps
-0.3997621612998304
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
44981746
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-16275000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-440000
Quarters > 1 > balance Sheet > cash
77596000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
80439000
Quarters > 1 > balance Sheet > property Plant Equipment
11110000
Quarters > 1 > balance Sheet > total Assets
92566000
Quarters > 1 > balance Sheet > payables
2774000
Quarters > 1 > balance Sheet > short Term Debt
3854000
Quarters > 1 > balance Sheet > long Term Debt
24705000
Quarters > 1 > balance Sheet > total Liabilities
51102000
Quarters > 1 > balance Sheet > equity
41464000
Quarters > 1 > cash Flow > net Income
-17982000
Quarters > 1 > cash Flow > depreciation
406000
Quarters > 1 > cash Flow > change In Working Capital
-75000
Quarters > 1 > cash Flow > cash From Operations
-15164000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
388000
Quarters > 1 > cash Flow > net Change In Cash
-14776000
Quarters > 1 > ratios > PE
-0.3997621612998304
Quarters > 1 > ratios > PB
1.1933224146247348
Quarters > 1 > ratios > ROE
-43.36774069071966
Quarters > 1 > ratios > ROA
-19.426139187174556
Quarters > 1 > ratios > FCF
-15164000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
33
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
426000
Quarters > 2 > income Statement > gross Profit
-426000
Quarters > 2 > income Statement > operating Expenses
17565000
Quarters > 2 > income Statement > operating Income
-17991000
Quarters > 2 > income Statement > interest Expense
1263000
Quarters > 2 > income Statement > pretax Income
-18089000
Quarters > 2 > income Statement > net Income
-18089000
Quarters > 2 > income Statement > eps
-0.4035276917727488
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
44827159
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-16400000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-98000
Quarters > 2 > balance Sheet > cash
92042000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
94457000
Quarters > 2 > balance Sheet > property Plant Equipment
11709000
Quarters > 2 > balance Sheet > total Assets
107236000
Quarters > 2 > balance Sheet > payables
986000
Quarters > 2 > balance Sheet > short Term Debt
1412000
Quarters > 2 > balance Sheet > long Term Debt
26585000
Quarters > 2 > balance Sheet > total Liabilities
49929000
Quarters > 2 > balance Sheet > equity
57307000
Quarters > 2 > cash Flow > net Income
-18089000
Quarters > 2 > cash Flow > depreciation
426000
Quarters > 2 > cash Flow > change In Working Capital
-432000
Quarters > 2 > cash Flow > cash From Operations
-18948000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-18948000
Quarters > 2 > ratios > PE
-0.4035276917727488
Quarters > 2 > ratios > PB
0.8604511647791718
Quarters > 2 > ratios > ROE
-31.565079309682936
Quarters > 2 > ratios > ROA
-16.868402402178372
Quarters > 2 > ratios > FCF
-18948000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
37
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
-49000
Quarters > 3 > income Statement > cost Of Revenue
442000
Quarters > 3 > income Statement > gross Profit
-967000
Quarters > 3 > income Statement > operating Expenses
20348000
Quarters > 3 > income Statement > operating Income
-20348000
Quarters > 3 > income Statement > interest Expense
1267000
Quarters > 3 > income Statement > pretax Income
-20400000
Quarters > 3 > income Statement > net Income
-20400000
Quarters > 3 > income Statement > eps
-0.4586522727793923
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
44478140
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-18691000
Quarters > 3 > income Statement > operating Margin
41526.5306122449
Quarters > 3 > income Statement > total Other Income Expense Net
-52000
Quarters > 3 > balance Sheet > cash
110995000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
113066000
Quarters > 3 > balance Sheet > property Plant Equipment
12323000
Quarters > 3 > balance Sheet > total Assets
126929000
Quarters > 3 > balance Sheet > payables
3035000
Quarters > 3 > balance Sheet > short Term Debt
1557000
Quarters > 3 > balance Sheet > long Term Debt
26095000
Quarters > 3 > balance Sheet > total Liabilities
53539000
Quarters > 3 > balance Sheet > equity
73390000
Quarters > 3 > cash Flow > net Income
-20400000
Quarters > 3 > cash Flow > depreciation
442000
Quarters > 3 > cash Flow > change In Working Capital
458000
Quarters > 3 > cash Flow > cash From Operations
-14252000
Quarters > 3 > cash Flow > capital Expenditures
123000
Quarters > 3 > cash Flow > cash From Investing
-123000
Quarters > 3 > cash Flow > cash From Financing
2547000
Quarters > 3 > cash Flow > net Change In Cash
-11828000
Quarters > 3 > ratios > PE
-0.4586522727793923
Quarters > 3 > ratios > PB
0.6666569559885543
Quarters > 3 > ratios > ROE
-27.796702548031067
Quarters > 3 > ratios > ROA
-16.07197724712241
Quarters > 3 > ratios > FCF
-14375000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
293.3673469387755
Quarters > 3 > health Score
48
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
1885000
Annuals > 0 > income Statement > cost Of Revenue
1814000
Annuals > 0 > income Statement > gross Profit
71000
Annuals > 0 > income Statement > operating Expenses
73665000
Annuals > 0 > income Statement > operating Income
-73594000
Annuals > 0 > income Statement > interest Expense
4656000
Annuals > 0 > income Statement > pretax Income
-70515000
Annuals > 0 > income Statement > net Income
-70515000
Annuals > 0 > income Statement > eps
-1.6077414546540987
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
43859664
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-64045000
Annuals > 0 > income Statement > operating Margin
-3904.190981432361
Annuals > 0 > income Statement > total Other Income Expense Net
3079000
Annuals > 0 > balance Sheet > cash
110995000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
113066000
Annuals > 0 > balance Sheet > property Plant Equipment
12323000
Annuals > 0 > balance Sheet > total Assets
126929000
Annuals > 0 > balance Sheet > payables
3035000
Annuals > 0 > balance Sheet > short Term Debt
1557000
Annuals > 0 > balance Sheet > long Term Debt
26095000
Annuals > 0 > balance Sheet > total Liabilities
53539000
Annuals > 0 > balance Sheet > equity
73390000
Annuals > 0 > cash Flow > net Income
-70515000
Annuals > 0 > cash Flow > depreciation
1814000
Annuals > 0 > cash Flow > change In Working Capital
2526000
Annuals > 0 > cash Flow > cash From Operations
-56188000
Annuals > 0 > cash Flow > capital Expenditures
254000
Annuals > 0 > cash Flow > cash From Investing
-254000
Annuals > 0 > cash Flow > cash From Financing
13080000
Annuals > 0 > cash Flow > net Change In Cash
-43362000
Annuals > 0 > ratios > PE
-1.6077414546540987
Annuals > 0 > ratios > PB
0.5976245265022483
Annuals > 0 > ratios > ROE
-96.08257255756915
Annuals > 0 > ratios > ROA
-55.5546801755312
Annuals > 0 > ratios > FCF
-56442000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-29.94270557029178
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
19943000
Annuals > 1 > income Statement > cost Of Revenue
1764000
Annuals > 1 > income Statement > gross Profit
18179000
Annuals > 1 > income Statement > operating Expenses
58682000
Annuals > 1 > income Statement > operating Income
-40503000
Annuals > 1 > income Statement > interest Expense
3139000
Annuals > 1 > income Statement > pretax Income
-37368000
Annuals > 1 > income Statement > net Income
-37368000
Annuals > 1 > income Statement > eps
-1.0482915439947493
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
35646572
Annuals > 1 > income Statement > income Tax Expense
1596105
Annuals > 1 > income Statement > EBITDA
-32465000
Annuals > 1 > income Statement > operating Margin
-203.09381737953169
Annuals > 1 > income Statement > total Other Income Expense Net
3135000
Annuals > 1 > balance Sheet > cash
134343000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
1350000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
138370000
Annuals > 1 > balance Sheet > property Plant Equipment
14846000
Annuals > 1 > balance Sheet > total Assets
174833000
Annuals > 1 > balance Sheet > payables
1336000
Annuals > 1 > balance Sheet > short Term Debt
8275000
Annuals > 1 > balance Sheet > long Term Debt
32656000
Annuals > 1 > balance Sheet > total Liabilities
63459000
Annuals > 1 > balance Sheet > equity
111374000
Annuals > 1 > cash Flow > net Income
-37368000
Annuals > 1 > cash Flow > depreciation
1764000
Annuals > 1 > cash Flow > change In Working Capital
-5894000
Annuals > 1 > cash Flow > cash From Operations
-32612000
Annuals > 1 > cash Flow > capital Expenditures
769000
Annuals > 1 > cash Flow > cash From Investing
-769000
Annuals > 1 > cash Flow > cash From Financing
58429000
Annuals > 1 > cash Flow > net Change In Cash
25048000
Annuals > 1 > ratios > PE
-1.0482915439947493
Annuals > 1 > ratios > PB
0.3200618815881624
Annuals > 1 > ratios > ROE
-33.55181640239194
Annuals > 1 > ratios > ROA
-21.37353932038002
Annuals > 1 > ratios > FCF
-33381000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-1.6738203881061025
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
16401000
Annuals > 2 > income Statement > cost Of Revenue
2510000
Annuals > 2 > income Statement > gross Profit
16401000
Annuals > 2 > income Statement > operating Expenses
72457000
Annuals > 2 > income Statement > operating Income
-56056000
Annuals > 2 > income Statement > interest Expense
1104000
Annuals > 2 > income Statement > pretax Income
-53810000
Annuals > 2 > income Statement > net Income
-51564000
Annuals > 2 > income Statement > eps
-1.7864467849223946
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
28864000
Annuals > 2 > income Statement > income Tax Expense
-2246000
Annuals > 2 > income Statement > EBITDA
-54952000
Annuals > 2 > income Statement > operating Margin
-341.78403755868544
Annuals > 2 > income Statement > total Other Income Expense Net
2246000
Annuals > 2 > balance Sheet > cash
129315000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
6928000
Annuals > 2 > balance Sheet > inventories
2
Annuals > 2 > balance Sheet > total Current Assets
140200000
Annuals > 2 > balance Sheet > property Plant Equipment
17451000
Annuals > 2 > balance Sheet > total Assets
160245000
Annuals > 2 > balance Sheet > payables
1221000
Annuals > 2 > balance Sheet > short Term Debt
2084000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
37908000
Annuals > 2 > balance Sheet > equity
122337000
Annuals > 2 > cash Flow > net Income
-53810000
Annuals > 2 > cash Flow > depreciation
1104000
Annuals > 2 > cash Flow > change In Working Capital
2539000
Annuals > 2 > cash Flow > cash From Operations
-40596000
Annuals > 2 > cash Flow > capital Expenditures
3611000
Annuals > 2 > cash Flow > cash From Investing
-3611000
Annuals > 2 > cash Flow > cash From Financing
15906000
Annuals > 2 > cash Flow > net Change In Cash
-28301000
Annuals > 2 > ratios > PE
-1.7864467849223946
Annuals > 2 > ratios > PB
0.2359384323630627
Annuals > 2 > ratios > ROE
-42.14914539346232
Annuals > 2 > ratios > ROA
-32.17822708976879
Annuals > 2 > ratios > FCF
-44207000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-2.695384427778794
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
4148000
Annuals > 3 > income Statement > cost Of Revenue
735000
Annuals > 3 > income Statement > gross Profit
-735000
Annuals > 3 > income Statement > operating Expenses
50087000
Annuals > 3 > income Statement > operating Income
-50087000
Annuals > 3 > income Statement > interest Expense
216000
Annuals > 3 > income Statement > pretax Income
-49983000
Annuals > 3 > income Statement > net Income
-49767000
Annuals > 3 > income Statement > eps
-2.6966675697642914
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
18455000
Annuals > 3 > income Statement > income Tax Expense
-216000
Annuals > 3 > income Statement > EBITDA
-49871000
Annuals > 3 > income Statement > operating Margin
-1207.4975891996144
Annuals > 3 > income Statement > total Other Income Expense Net
104000
Annuals > 3 > balance Sheet > cash
157531000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
161068000
Annuals > 3 > balance Sheet > property Plant Equipment
16325000
Annuals > 3 > balance Sheet > total Assets
179250000
Annuals > 3 > balance Sheet > payables
2037000
Annuals > 3 > balance Sheet > short Term Debt
1072000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
26463000
Annuals > 3 > balance Sheet > equity
152787000
Annuals > 3 > cash Flow > net Income
-49983000
Annuals > 3 > cash Flow > depreciation
216000
Annuals > 3 > cash Flow > change In Working Capital
2277000
Annuals > 3 > cash Flow > cash From Operations
-42876000
Annuals > 3 > cash Flow > capital Expenditures
498000
Annuals > 3 > cash Flow > cash From Investing
-498000
Annuals > 3 > cash Flow > cash From Financing
109427000
Annuals > 3 > cash Flow > net Change In Cash
66053000
Annuals > 3 > ratios > PE
-2.6966675697642914
Annuals > 3 > ratios > PB
0.12078907236872247
Annuals > 3 > ratios > ROE
-32.5727974238646
Annuals > 3 > ratios > ROA
-27.764016736401675
Annuals > 3 > ratios > FCF
-43374000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-10.456605593056896
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.3573920397680187
Valuation > metrics > PB
1.7013725332612957
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-55.27790909704869
Profitability > metrics > ROA
-24.012438942103177
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.6888296076180185
Risk > metrics > Interest Coverage
-24.419254658385093
Risk > final Score
-68
Risk > verdict
High
Liquidity > metrics > Current Ratio
7.943719412724307
Liquidity > metrics > Quick Ratio
7.943719412724307
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
30
Prev Risks > 0
-24
Prev Risks > 1
-9
Prev Risks > 2
-16
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:37:35.770Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-06
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.36
Earnings History > 0 > eps Estimate
-0.388
Earnings History > 0 > eps Difference
0.028
Earnings History > 0 > surprise Percent
7.2165
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-14
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.4
Earnings History > 1 > eps Estimate
-0.47
Earnings History > 1 > eps Difference
0.07
Earnings History > 1 > surprise Percent
14.8936
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-08
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.4
Earnings History > 2 > eps Estimate
-0.38
Earnings History > 2 > eps Difference
-0.02
Earnings History > 2 > surprise Percent
-5.2632
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-11
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.46
Earnings History > 3 > eps Estimate
-0.42
Earnings History > 3 > eps Difference
-0.04
Earnings History > 3 > surprise Percent
-9.5238
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-08
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.38
Earnings History > 4 > eps Estimate
-0.41
Earnings History > 4 > eps Difference
0.03
Earnings History > 4 > surprise Percent
7.3171
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.43
Earnings History > 5 > eps Estimate
-0.38
Earnings History > 5 > eps Difference
-0.05
Earnings History > 5 > surprise Percent
-13.1579
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-03
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.39
Earnings History > 6 > eps Estimate
-0.35
Earnings History > 6 > eps Difference
-0.04
Earnings History > 6 > surprise Percent
-11.4286
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-07
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.33
Earnings History > 7 > eps Estimate
-0.43
Earnings History > 7 > eps Difference
0.1
Earnings History > 7 > surprise Percent
23.2558
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-14
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.23
Earnings History > 8 > eps Estimate
-0.39
Earnings History > 8 > eps Difference
0.16
Earnings History > 8 > surprise Percent
41.0256
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.14
Earnings History > 9 > eps Estimate
-0.42
Earnings History > 9 > eps Difference
0.28
Earnings History > 9 > surprise Percent
66.6667
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-11
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.34
Earnings History > 10 > eps Estimate
-0.5
Earnings History > 10 > eps Difference
0.16
Earnings History > 10 > surprise Percent
32
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-23
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.39
Earnings History > 11 > eps Estimate
-0.55
Earnings History > 11 > eps Difference
0.16
Earnings History > 11 > surprise Percent
29.0909
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-10
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.4
Earnings History > 12 > eps Estimate
-0.6
Earnings History > 12 > eps Difference
0.2
Earnings History > 12 > surprise Percent
33.3333
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-11
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.53
Earnings History > 13 > eps Estimate
-0.43
Earnings History > 13 > eps Difference
-0.1
Earnings History > 13 > surprise Percent
-23.2558
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-10
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.56
Earnings History > 14 > eps Estimate
-0.61
Earnings History > 14 > eps Difference
0.05
Earnings History > 14 > surprise Percent
8.1967
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-24
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.66
Earnings History > 15 > eps Estimate
-0.53
Earnings History > 15 > eps Difference
-0.13
Earnings History > 15 > surprise Percent
-24.5283
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-10
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.51
Earnings History > 16 > eps Estimate
-0.44
Earnings History > 16 > eps Difference
-0.07
Earnings History > 16 > surprise Percent
-15.9091
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-12
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-3.82
Earnings History > 17 > eps Estimate
-0.37
Earnings History > 17 > eps Difference
-3.45
Earnings History > 17 > surprise Percent
-932.4324
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-06-10
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-83.36
Earnings History > 18 > eps Estimate
-0.46
Earnings History > 18 > eps Difference
-82.9
Earnings History > 18 > surprise Percent
-18021.7391
Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. The company designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies through its proprietary PREDATOR platform. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced or metastatic solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of advanced or metastatic solid tumors and lymphoma. The company is also developing JZP898, a conditionally activated interferon alpha INDUKINE molecule for the treatment of cancer; WTX-921, a conditionally activated IL-10 INDUKINE molecule for the treatment of inflammatory bowel disease and potentially other inflammatory diseases; and WTX-712, an activated Interleukin-21(IL-21) and WTX-518, an activated IL-18 (IL-18) INDUKINE molecule for the treatment of cancer. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Watertown, Massachusetts.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AWerewolf Therapeutics (NASDAQ:HOWL) Director Sells 17,858 Shares MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$6.1667
Analyst Picks
Strong Buy
4
Buy
2
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 51.40% of the total shares of Werewolf Therapeutics Inc
1.
RA Capital Management, LLC(14.6107%)
since
2025/06/30
2.
Mpm Asset Management, LLC(9.4248%)
since
2025/06/30
3.
MPM Oncology Impact Management LP(5.2676%)
since
2025/06/30
4.
Bank of America Corp(4.6557%)
since
2025/06/30
5.
Vanguard Group Inc(2.839%)
since
2025/06/30
6.
Vanguard Total Stock Mkt Idx Inv(1.9169%)
since
2025/07/31
7.
Millennium Management LLC(1.5235%)
since
2025/06/30
8.
Sphera Funds Management Ltd.(1.3707%)
since
2025/06/30
9.
DC Funds, LP(1.2882%)
since
2025/06/30
10.
Partner Fund Management LP(0.8771%)
since
2025/06/30
11.
Jane Street Group LLC(0.8199%)
since
2025/06/30
12.
BlackRock Inc(0.7916%)
since
2025/06/30
13.
Geode Capital Management, LLC(0.7172%)
since
2025/06/30
14.
Renaissance Technologies Corp(0.6917%)
since
2025/06/30
15.
Vanguard Institutional Extnd Mkt Idx Tr(0.6228%)
since
2025/07/31
16.
Alyeska Investment Group, L.P.(0.5154%)
since
2025/06/30
17.
Goldman Sachs Group Inc(0.4974%)
since
2025/06/30
18.
Fidelity Extended Market Index(0.363%)
since
2025/07/31
19.
State Street Corp(0.2606%)
since
2025/06/30
20.
A4Investments SICAV SIF ACCI IlanaA2EURH(0.2575%)
since
2025/08/31
21.
Marshall Wace Asset Management Ltd(0.227%)
since
2025/06/30
22.
Bridgeway Capital Management, LLC(0.2231%)
since
2025/06/30
23.
Bridgeway Ultra-Small Company Market(0.2187%)
since
2025/06/30
24.
AQR Capital Management LLC(0.2016%)
since
2025/06/30
25.
Y-Intercept (Hong Kong) Ltd(0.1846%)
since
2025/06/30
26.
Vifag 2002 SICAV(0.1531%)
since
2025/07/31
27.
Fidelity Total Market Index(0.1202%)
since
2025/07/31
28.
Extended Equity Market Fund K(0.1199%)
since
2025/06/30
29.
Fidelity Series Total Market Index(0.0932%)
since
2025/07/31
30.
NT Ext Equity Mkt Idx Fd - L(0.0867%)
since
2025/06/30
31.
Northern Trust Extended Eq Market Idx(0.0867%)
since
2025/06/30
32.
Spartan Extended Market Index Pool F(0.0757%)
since
2025/07/31
33.
NT Col R2000 Val Idx Fd -DC -L -TierFour(0.0559%)
since
2025/03/31
34.
NT Ext Equity Mkt Idx Fd - NL(0.0539%)
since
2025/06/30
35.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0419%)
since
2025/06/30
36.
Spartan Total Market Index Pool G(0.0406%)
since
2025/07/31
37.
Fidelity Nasdaq Composite Index(0.0281%)
since
2025/07/31
38.
State Street Russell 2000 Value CIT(0.0273%)
since
2025/03/31
39.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0245%)
since
2025/06/30
40.
Vanguard U.S. Eq Idx £ Acc(0.0226%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.36
EPS Estimate
-0.388
EPS Difference
0.028
Surprise Percent
7.2165%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.